Back to Search
Start Over
Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
- Source :
-
Frontiers in immunology [Front Immunol] 2020 Oct 06; Vol. 11, pp. 581338. Date of Electronic Publication: 2020 Oct 06 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Objectives: The severity of Coronavirus Disease 2019 (COVID-19) is largely determined by the immune response. First studies indicate altered lymphocyte counts and function. However, interactions of pro- and anti-inflammatory mechanisms remain elusive. In the current study we characterized the immune responses in patients suffering from severe COVID-19-induced acute respiratory distress syndrome (ARDS).<br />Methods: This was a single-center retrospective study in patients admitted to the intensive care unit (ICU) with confirmed COVID-19 between March 14 <superscript>th</superscript> and May 28 <superscript>th</superscript> 2020 (n = 39). Longitudinal data were collected within routine clinical care, including flow-cytometry of lymphocyte subsets, cytokine analysis and growth differentiation factor 15 (GDF-15). Antibody responses against the receptor binding domain (RBD) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike protein were analyzed.<br />Results: All patients suffered from severe ARDS, 30.8% died. Interleukin (IL)-6 was massively elevated at every time-point. The anti-inflammatory cytokine IL-10 was concomitantly upregulated with IL-6. The cellular response was characterized by lymphocytopenia with low counts of CD8+ T cells, natural killer (NK) and naïve T helper cells. CD8+ T and NK cells recovered after 8 to 14 days. The B cell system was largely unimpeded. This coincided with a slight increase in anti-SARS-CoV-2-Spike-RBD immunoglobulin (Ig) G and a decrease in anti-SARS-CoV-2-Spike-RBD IgM. GDF-15 levels were elevated throughout ICU treatment.<br />Conclusions: Massively elevated levels of IL-6 and a delayed cytotoxic immune defense characterized severe COVID-19-induced ARDS. The B cell response and antibody production were largely unimpeded. No obvious imbalance of pro- and anti-inflammatory mechanisms was observed, with elevated GDF-15 levels suggesting increased tissue resilience.<br /> (Copyright © 2020 Notz, Schmalzing, Wedekink, Schlesinger, Gernert, Herrmann, Sorger, Weismann, Schmid, Sitter, Schlegel, Kranke, Wischhusen, Meybohm and Lotz.)
- Subjects :
- Aged
Antibodies, Viral blood
Antibodies, Viral immunology
COVID-19
Coronavirus Infections immunology
Cytokine Release Syndrome immunology
Female
Growth Differentiation Factor 15 blood
Humans
Immunoglobulin G blood
Immunoglobulin G immunology
Intensive Care Units
Interleukin-10 blood
Interleukin-6 blood
Longitudinal Studies
Lymphopenia
Male
Middle Aged
Pandemics
Pilot Projects
Pneumonia, Viral immunology
Retrospective Studies
SARS-CoV-2
Severe Acute Respiratory Syndrome immunology
Spike Glycoprotein, Coronavirus immunology
Betacoronavirus immunology
Coronavirus Infections pathology
Cytokine Release Syndrome pathology
Pneumonia, Viral pathology
Severe Acute Respiratory Syndrome pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 11
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 33123167
- Full Text :
- https://doi.org/10.3389/fimmu.2020.581338